showed that in elderly glioblastoma patients, higher IFITM2 expression and an inflammatory environment lead to poorer survival, with IFITM2 driven by IFN‐γ contributing to the aggressive cancer phenotype.30 This evidence concerns the gene IFNG and glioblastoma.